Parkinson’s disease (PD), the second-most common neurodegenerative disease, is characterized by motor and nonmotor symptoms. PD is often misdiagnosed; inappropriate treatment due to misdiagnosis has ...
January 17, 2011 — GE Healthcare has announced Food and Drug Administration (FDA) approval of ioflupane iodine-123 injection (DaTscan), a contrast agent for use with single-photon emission computed ...
Single-photon emission computerized tomography (SPECT/CT) systems are a key tool to diagnose and monitor diseases, but for the past sixty years the technology has remained more or less the same. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback